Previous 10 | Next 10 |
Doximity ( NYSE: DOCS ), which is currently down 9% in Wednesday afternoon trading, fell below its IPO price of $26 during the trading session. At its lowest, the share price reached $25, also a 52-week low. Trading is also heavy in the stock today. Normal daily vo...
The last year has been brutal, especially for tech investors. The Nasdaq Composite remains in bear-market territory, down 22% over the last 12-month stretch and some 30% off of its all-time high. Things have been even worse for many individual tech stocks. Many quality companies are bei...
Healthcare stocks have been some of the worst-performing equities over the prior 12 months. And medically oriented companies with growth-dependent valuations have been particularly hard hit by this moody market. Doximity (NYSE: DOCS) , which owns and operates the largest digital...
Tech giant Amazon (NASDAQ: AMZN) was in the bidding for home health company Signify Health but ended up losing out to CVS Health . It may have been a disappointment for investors who were hoping Amazon would deepen its footprint in healthcare. However, there are three ot...
Telehealth stock Doximity (NYSE: DOCS) tumbled 21.6% in August, according to data provided by S&P Global Market Intelligence , following weak earnings guidance. Things only got worse as investors pulled out of growth stocks with high valua...
In this podcast, Motley Fool senior analysts Jason Moser and Emily Flippen discuss: Plus, Motley Fool senior analyst Maria Gallagher talks with Harvard Business School professor Ranjay Gulati about key insights from his book Deep Purpose: The Heart and Soul of High-Performance Compani...
As of Aug. 23, 2022, shares of Doximity (NYSE: DOCS) are down nearly 68% from their all-time high and have lost to the market by a wide margin this year. Does that mean shares are worth buying today? Check out this short video to learn more, consider subscribing, and click the speci...
The 2022 bear market continues to wreak havoc on high-growth stocks. With the Federal Reserve poised to continue hiking interest rates in an attempt to get inflation back under control, many stocks remain under pressure -- especially those that either don't yet turn a profit, or generate mi...
The stock market has been rallying of late as many struggling stocks have emerged from deeply discounted valuations. But just because you didn't buy near the bottom doesn't mean this isn't a good time to invest. There is no shortage of promising growth stocks that you can justify adding to ...
Direct-to-patient healthcare is the future. H&H's mission is to make healthcare accessible, affordable, and convenient for everyone. Marketing Expense needs to slow down — a test of sustainable scalability. Management raised full-year guidance — a sign of bus...
News, Short Squeeze, Breakout and More Instantly...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Doximity, Inc. (NYSE: DOCS). On August 8, 2023, the Company disclosed disappointing guidance ...
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2024 after market close on August 8, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p...
2024-07-10 22:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...